Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
Menon, Venu
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy. [electronic resource] - Journal of the American Heart Association 01 2020 - e014328 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
2047-9980
10.1161/JAHA.119.014328 doi
Aged
Biomarkers--blood
Blood Glucose--drug effects
Cardiovascular Diseases--mortality
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Female
Glycated Hemoglobin--metabolism
Glycemic Control
Heart Disease Risk Factors
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypoglycemic Agents--therapeutic use
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Risk Assessment
Time Factors
Treatment Outcome
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy. [electronic resource] - Journal of the American Heart Association 01 2020 - e014328 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
2047-9980
10.1161/JAHA.119.014328 doi
Aged
Biomarkers--blood
Blood Glucose--drug effects
Cardiovascular Diseases--mortality
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Female
Glycated Hemoglobin--metabolism
Glycemic Control
Heart Disease Risk Factors
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypoglycemic Agents--therapeutic use
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Risk Assessment
Time Factors
Treatment Outcome